Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB00726ApprovedInvestigationalSmall moleculeAntidepressive Agents Indicated for DepressionAntidepressive Agents, Tricyclic
Trimipramine is a tricyclic antidepressant used to treat depression. Tricyclic antidepressant similar to imipramine, but with more antihistaminic and sedative properties.
- Mechanism
- Curator reviewed
Trimipramine's mechanism of action differs from other tricyclic antidepressants. Trimipramine acts by decreasing the reuptake of norepinephrine and serotonin (5-HT).
- Primary indication
- For the treatment of depression and depression accompanied by anxiety, agitation or sleep disturbanceCurator reviewed · 3 structured indications
- Formula / weight
- C20H26N2 · 294.4338 g/mol (avg)
- First approval
- Canada, 2000 · United States, 1990
- Also known as
- Trimeprimine · Trimeproprimine
- Code names
- IF 6120 · IL 6001 · RP-7162
Resolves to
Clinical / RWD
Structure
InChIKey
ZSCDBOWYZJWBIY-UHFFFAOYSA-NSMILESCC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12Targets
Transporters
What you can answer from here — as of September 23, 2026
19Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
Which drugs share a target with Trimipramine, and which of those have an active Phase 3 trial?